A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An Illinois Cancer Center Study.

Source:http://linkedlifedata.com/resource/pubmed/id/8364875

Cancer 1993 Sep 15 72 6 1965-8

Download in:

View as

Triples

General Info

PMID
8364875